The results surpass other available options
While GLP-1 and GLP-1/GIP medications are generally considered cost-effective for treating obesity in targeted populations [65,66,67], alternative strategiessuch as expanding bariatric surgery access, enhancing lifestyle intervention programmes, pharmaceutical management of cardiometabolic comorbidities, or population-level policiesshould also be considered
The synergy between L-Carnitine and exercise is exactly that: a supportive, science-backed way to give your fat loss efforts a solid boost
Experts analysed alcohol-related hospital admissions for 40,703 people who had started either semaglutide, which includes the brand Wegovy, or tirzepatide, also known as Mounjaro, between January 2018 and December 2024
Insurance and Prior Authorization Made Simple at Klinic Navigating the complexities of insurance can hinder starting on GLP-1 medications, but Klinic in Tustin, California, simplifies this process by managing insurance verification and prior authorization on your behalf